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Abstract
Background: Micromeria croatica (Pers.) Schott is an aromatic plant from Lamiaceae family previously found to
possess potent in vitro antioxidant activity which is mainly attributed to the high level of polyphenolic substances.
The aim of this study was to investigate the hepatoprotective activity and possible underlying mechanisms of
Micromeria croatica ethanolic extract (MC) using a model of carbon tetrachloride (CCl4)-induced liver injury in mice.
Methods: Male BALB/cN mice were randomly divided into seven groups: control group received saline, MC group
received ethanolic extract of M. croatica in 5 % DMSO (100 mg/kg b.w., p.o.), and CCl4 group was administered CCl4
dissolved in corn oil (2 mL/kg, 10 % v/v, ip). MC50, MC200 and MC400 groups were treated with MC orally at doses
of 50, 200 and 400 mg/kg once daily for 2 consecutive days, respectively, 6 h after CCl4 intoxication. The reference
group received silymarin at dose of 400 mg/kg. At the end of experiment, blood and liver samples were collected
for biochemical, histopathological, immunohistochemical and Western blot analyses. In addition, major phenolic
compounds in MC were quantified by HPLC-DAD.
Results: CCl4 intoxication resulted in liver cells damage and oxidative stress and triggered inflammatory response in
mice livers. MC treatment decreased ALT activity and prevented liver necrosis. Improved hepatic antioxidant status
was evident by increased Cu/Zn SOD activity and decreased 4-hydroxynonenal (4-HNE) formation in the livers.
Concomitantly, nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) were overexpressed.
The hepatoprotective activity of MC was accompanied by the increase in nuclear factor-kappaB (NF-κB) activation
and tumor necrosis factor-alpha (TNF-α) expression, indicating amelioration of hepatic inflammation. Additionally,
MC prevented tumor growth factor-β1 (TGF-β1) and α-smooth muscle actin (α-SMA) expression, suggesting the
potential for suppression of hepatic fibrogenesis.
Conclusion: These results of the present study demonstrated that MC possesses in vivo antioxidant and anti-
inflammatory activity and exhibits antifibrotic potential, which are comparable to those of standard hepatoprotective
compound silymarin.
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Background
Liver diseases represent one of a major health burdens
worldwide and a common cause of death in Western
countries [1]. Etiologically, various infectious agents in-
cluding viruses and hepatotoxic chemicals along with
environmental pollutants are responsible for different
types of liver disease. Hepatic damage is a fundamental
pathological process in most of them, and long-standing
liver injury leads to fibrosis, cirrhosis and even hepato-
cellular carcinoma. Recent research in the field of free
radical biology suggested an important pathophysio-
logical role of free radicals and oxidative stress in the de-
velopment and progression of liver diseases [2]. The
overproduction of free radicals and other reactive oxy-
gen species (ROS) in the liver cells is considered to
cause oxidative damage of vital cellular macromolecules
such as lipids, proteins and nucleic acids, leading to cell
dysfunction and death. Natural antioxidants can prevent
free radical-mediated oxidative damage to cellular com-
ponents by acting at different levels in the pathophysio-
logical chain. A number of plant extracts and their
constituents have been shown to possess hepatoprotec-
tive properties by improving the antioxidant status in
vivo [3–5]. Plant-derived antioxidants may therefore be
particularly important in reducing the incidence of vari-
ous liver disorders as well as other oxidative stress-
related diseases.
In spite of an increasing need for agents to protect the
liver from damage, modern medicine still lacks a reliable
liver-protective drug. Therefore, numerous edible and
medicinal plants have been studied to evaluate their hepa-
toprotective efficiency. The genus Micromeria Bentham
(Lamiaceae, Nepetoidae) contains about 70 species with a
distribution range extending from the Himalayan region
to the Macaronesian Archipelago and from the Mediterra-
nean to South Africa and Madagascar. All species are per-
ennial of annual herbs, subshrub or shrub, often with an
aromatic scent [6]. Some of them are traditionally used
against colds, headache, stomach diseases, liver and heart
disorders, wounds and skin infections, as well as for in-
secticidal, herbicidal and food-related purposes. Besides
being used as culinary herbs, the tea from their leaves has
been consumed as a beverage [7–9]. Micromeria species
are reported to have various in vitro biological effects in-
cluding antioxidant [10], antimicrobial [11], anticholines-
terase [12], anti-inflammatory and analgesic activities [13],
and therefore they have a great potential for use as herbal
drugs or dietary supplements.
Micromeria croatica (Pers.) Schott is one of nine
Micromeria species growing in Croatia. It is an endemic
species of Croatia and some neighbouring countries
which grows in crevices of calcareous rocks at altitudes
of 150 to 2000 m [14]. Previous phytochemical investiga-
tions of this plant revealed the presence of flavonoid
glycosides of luteolin and apigenin [15] and essential oil
rich in caryophyllene oxide [16]. Recently we reported
that some Micromeria species possess considerable anti-
oxidant activities, mainly attributed to the high level of
polyphenolic substances [10]. These results suggested
that Micromeria species, especially M. croatica, could be
useful in prevention and/or treatment of human diseases
in which free radicals and other ROS have been impli-
cated. Therefore, the present study aimed to evaluate
protective effect of M. croatica ethanolic extract (MC)
against acute liver injury and fibrosis induced by CCl4 as
well as to elucidate a possible mechanism of its
hepatoprotection.
Methods
Plant material and extraction
Aerial parts of wild-growing Micromeria croatica were
collected at the full flowering stage in July 2011 in
Croatia from South Velebit Mt. (950 m a.s.l.). The plant
sample was authenticated by the Department of Pharma-
cognosy, Faculty of Pharmacy and Biochemistry and De-
partment of Botany and Botanical Garden, Faculty of
Science (University of Zagreb, Croatia) where the vou-
cher specimen has been deposited under the genus
number 812a.
Air-dried and pulverized plant material (20.00 g) was
extracted with 70 % ethanol (200 mL) using an ultra-
sonic bath (Bandelin Sonorex Digital 10 P, Berlin,
Germany) for 30 min. The extract was then filtered
through Whatman No. 1 paper using a Büchner funnel
and the residue was then re-extracted with the same
solvent (200 mL) as described above. Obtained extracts
were combined and lyophilized.
For HPLC analysis, the lyophilized M. croatica extract
was redissolved in HPLC grade methanol to make 5 mg/mL
sample solution, then filtered through a 0.45 μm membrane
filter (Millipore, USA). Clear pale green filtrate was obtained
and immediately used.
Chemicals and antibodies
Silymarin, bovine serum albumin (BSA), bovine Cu/Zn
superoxide dismutase (SOD), xanthine, xanthine oxidase,
cytochrome c and Entelan were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Carbon tetrachloride
(CCl4) was obtained from Kemika, Zagreb, Croatia.
Diagnostic kit for the serum alanine aminotransferase
(ALT) was from Dijagnostika (Sisak, Croatia). Mouse
monoclonal antibodies to tumor necrosis factor-α (TNF-α)
(ab1793), α-smooth muscle actin (α-SMA) (ab18460),
rabbit polyclonal antibodies to 4-hydroxynonenal (4-HNE)
(ab46545), nuclear factor-kappaB (NF-κB), nuclear factor
erythroid 2-related factor 2 (Nrf2) (ab31163), heme
oxygenase-1 (HO-1) (ab13243) and transforming growth
factor-beta1 (TGF-β1) were purchased from Abcam
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(Cambridge, UK). DAKO EnVision + System was from
DAKO Corporation (Carpinteria, CA, USA). Radioimmu-
noprecipitation assay (RIPA) buffer (sc-24948) and milk
blocking reagent were purchased from Santa Cruz Biotech-
nology (Santa Cruz, CA, USA). Polyvinylidene fluoride
(PVDF) membrane was supplied from Roche Diagnostics
GmbH (Mannheim, Germany), while peroxidase-labeled
goat anti-mouse F(ab’)2 and Amersham ECL Prime from
Amersham Pharmacia Biotech (Uppsala, Sweden). All
other chemicals were of the highest analytical grade
available.
Determination of phenolic content of M. croatica
Identification and quantification of the major phenolic
constituents of M. croatica ethanolic extract was per-
formed using a slightly modified method of Fecka and
Turek [17]. HPLC analysis was conducted on an Agilent
1100 Series instrument (Agilent Technologies, Santa
Clara, CA, USA) equipped with an Agilent auto sampler,
a quaternary pump, a column thermostat, and a photo-
diode array detector. The separation was achieved using
a LichroCART®250-4 column (250 mm × 4.0 mm i.d.)
packed with LiChrospher® 100 RP-18e (5 μm) and pro-
tected by a suitable guard column. The chromatographic
method used was a gradient elution, using acidified
acetonitrile (5 % formic acid in acetonitrile, solvent A)
and acidified water (5 % formic acid in water, solvent B),
at a flow rate of 0.9 mL/min. The gradient employed
was as follows: 0 min, 15 % A; 25 min, 35 % A; 27 min,
70 % A; 32 min, 70 % A; 33 min, 100 % A; 38 min,
100 % A. Solvent solutions were vacuum degassed with
ultrasonication prior to usage. The injection volume for
the sample was 20 μL. All chromatographic experi-
ments were performed at 20 °C. The polyphenolic pro-
files were recorded at a wavelength of 330 nm.
Chromatographic data were acquired and processed
using HP ChemStation software. Phenolic acids were
identified in the sample based on their chromato-
graphic retention times and UV spectra, and quantified
by comparing integrated peak areas to calibration curves
prepared with corresponding analytical standards. The re-
sults were expressed in mg per g of the dry extract.
Animals
Male BALB/cN mice, 2 months old, weight 20-24 g,
were obtained from the breeding colony of the School of
Medicine, University of Rijeka, Croatia. The animals
were housed in standard environmental conditions and
had free access to tap water and a standard rodent diet
(pellet, type 4RF21 GLP, Mucedola, Italy). All experi-
mental procedures were conducted in compliance with
the Declaration of Helsinki principles and approved by
the Ethical Committee of the School of Medicine,
University of Rijeka, Croatia.
Experimental design
The experiment mice were randomly divided into seven
groups of five animals each. Control group received sa-
line and MC group received ethanolic extract of M.
croatica dissolved in DMSO and diluted with water
(5 % v/v), once daily for 2 days at dose of 400 mg/kg.
CCl4 group was administered CCl4 dissolved in corn oil
(2 mL/kg, 10 % v/v), intraperitoneally (ip). MC50,
MC200 and MC400 groups were treated with MC orally
at doses of 50, 200 and 400 mg/kg once daily for 2 con-
secutive days, respectively, 6 h after CCl4 intoxication.
The doses used were selected on the basis of our prelim-
inary studies (data not shown). Mice tolerated MC well,
without any signs of discomfort. The last group received
silymarin at dose of 400 mg/kg, which served as a refer-
ence. MC, silymarin and vehicle were given to mice after
ip administration of the combination of anaesthetic and
analgesic (Narketan/Xylapan). Anesthetized animals were
sacrificed 24 h after the last dose of MC, silymarin and ve-
hicle. Previously, blood was collected from the orbital
sinus and the serum was separated for determination of
ALT activity. The livers were removed, washed with saline,
blotted dry and divided into samples. Tissue specimens
were frozen in liquid nitrogen and stored at -80 °C if not
used for analysis immediately. Liver samples were used to
assess the Cu/Zn SOD activity, protein content and for
Western blot. Additionally, liver samples were preserved
in a 4 % paraformaldehyde solution for histology and
immunohistochemistry.
Biochemical analysis
Serum levels of ALT were measured using a Bio-Tek
EL808 Ultra Microplate Reader (BioTek Instruments,
Winooski, VT, USA) according to manufacturer’s
instructions.
Liver samples used for biochemical analysis were ho-
mogenized in 50 mM PBS (phosphate buffered saline,
pH 7.4) using a Polytron homogenizer (Kinematica,
Lucerne, Switzerland) and the supernatants were sepa-
rated using Beckman L7-65 Ultracentrifuge (Beckman,
Fullerton, USA) at 15,000 g for 20 min, at 4 °C. The su-
pernatants were used for determination of Cu/Zn SOD
activity, which was measured spectrophotometrically at
550 nm, based on the decrease in cytochrome c reduc-
tion by superoxide radicals generated in the xanthine/
xanthine oxidase system, as described previously [18].
Cu/Zn SOD activity was expressed as units per mg of
protein. The protein content in liver homogenates was
estimated by Bradford’s method [19].
Histopathological procedure
Liver tissues were placed in plastic cassettes and
immersed in 4 % paraformaldehyde for 48 h. The fixed
tissues were processed as described previously [20]. The
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degree of hepatocellular damage was evaluated by meas-
uring the area of necrosis in liver sections stained with
hematoxylin and eosin. For this purpose, we used light
microscopy (Olympus BX51, Tokyo, Japan). The necrotic
zones were manually selected and the percentage of nec-
rotic area was determined using the Cell F v3.1 software,
Olympus Soft Imaging Solutions (Münster, Germany).
Immunohistochemical analysis
For immunohistochemistry, 4 μm thick deparaffinised
liver tissue sections were used, as described earlier [20].
Briefly, deparaffinised liver slices were incubated over-
night with the antibodies against NF-κB, Nrf2 and α-
SMA. For antibody detection DAKO EnVision + System,
Peroxidase/DAB kit was employed. The sections were
then counterstained with hematoxylin, dehydrated using
graded alcohols and xylene, and mounted with Entelan.
The immunostaining intensity was analyzed by light mi-
croscopy (Olympus BX51, Tokyo, Japan). The Cell F v3.1
software, Olympus Soft Imaging Solutions (Münster,
Germany), was used to quantify immunohistochemical
staining across 10 high-power fields (400x).
Western blot analysis
Western blot analysis with monoclonal antibodies
against 4-HNE, TNF-α, HO-1 and TGF-β1 was per-
formed as described by [20]. Briefly, liver samples were
lysed in RIPA (radioimmunoprecipitation assay) buffer
with added protease inhibitors. Volumes equivalent to
50 μg of proteins were transferred to 12 % polyacryl-
amide gel. After electrophoresis, gels were blotted onto
polyvinylidene fluoride membrane. Membranes were
blocked overnight by milk blocking reagent at 4 °C. The
proteins were visualized by addition of the respective
antibodies, followed by peroxidase-labeled goat anti-
mouse F(ab’)2. The β-actin was used as a control of pro-
tein load. Membranes were washed with TBST buffer
(Tris–HCl-buffered saline, 50 mM, pH 7.5, with 0.1 %
Tween 20), incubated with Amersham ECL Prime (GE
Healthcare, Uppsala, Sweden) and scanned (Kodak
Image Station 440CF, Kodak, New Haven, CT, USA).
The intensity of the bands was quantified using ImageJ
software (NIH, Maryland, USA).
Statistical analysis
Data were analyzed using StatSoft STATISTICA version
10.0 software by Kruskal-Wallis test and post hoc compar-
isons were carried out with Dunn’s multiple comparison
test. Results of multiple comparisons tests were indicated
by different letters. Means with letters in common are not
significantly different from each other. Values in the text
are means ± standard deviation (SD). Differences with P <
0.05 were considered to be statistically significant.
Results
Phenolic content of M. croatica
HPLC was employed to generate chromatographic pro-
file of the Micromeria croatica ethanolic extract (MC)
Fig. 1 HPLC chromatogram of Micromeria croatica ethanolic extract recorded at 330 nm. The main compound was identified as rosmarinic
acid (Rt = 14.1 min)
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Table 1 Relative liver weight and serum ALT and Cu/Zn SOD activities in the livers of CCl4-intoxicated mice treated with Micrometria
croatica ethanolic extract (MC) and silymarin (S)
Relative liver weight ALT (U/L) Cu/Zn SOD (U/mg protein)
Control 4.59 ± 0.62a 26.5 ± 1.8a 9.36 ± 0.63a
MC 400 mg/kg 4.75 ± 0.44a 29.4 ± 2.1a 9.12 ± 0.94a
CCl4 7.76 ± 0.87
b 1447 ± 195b 5.22 ± 0.86b
CCl4 + MC 50 mg/kg 7.72 ± 0.46
b 1406 ± 165b 5.71 ± 0.74b
CCl4 + MC 200 mg/kg 6.88 ± 0.32
b 789 ± 107b 6.94 ± 0.37b
CCl4 + MC 400 mg/kg 5.75 ± 0.83
a 293 ± 79c 8.17 ± 0.69a
CCl4 + S 400 mg/kg 5.74 ± 0.71
a 256 ± 96c 8.29 ± 0.83a
Relative liver weight is expressed as g of liver weight/100 g of body weight
ALT alanine aminotransferase; Cu/Zn SOD superoxide dismutase
Each value represents the mean ± SD for 5 mice. Means sharing the same letter within row are not significantly different from each other (P < 0.05)
Fig. 2 Liver histopathology. Control mice (a), mice receiving MC orally at 400 mg/kg (b), CCl4-intoxicated mice (c), and mice secondary treated
with MC at doses of 50 mg/kg (d), 200 mg/kg (e) and 400 mg/kg (f) and silymarin at dose of 400 mg/kg (g). The necrotic area size measurement
(h). Representative results from 5 similarly treated mice. Each value represents the mean ± SD (n = 5). Means sharing the same letter are not
significantly different from each other (P < 0.05)
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and to identify and quantify major constituents. As
shown in Fig. 1, HPLC analysis revealed that rosmarinic
acid (Rt = 14.10 min) was the main phenolic acid existed
in the extract in amount of 9.95 mg/g extract. MC also
contained 1.26 mg/g of chlorogenic acid (Rt = 4.22 min)
and 0.47 mg/g of caffeic acid (Rt = 5.87 min), respectively.
Liver weight and serum markers of liver damage
As can be seen from Table 1, relative liver weight of
mice treated with the MC alone was similar to those of
control group. CCl4-intoxication induced a significant
increase in mice liver weight, which was significantly
ameliorated by administration of MC in a dose-dependent
manner. Serum ALT was significantly increased after CCl4
treatment (Table 1). Significant reduction of ALT activity
was determined in the serum of MC400 groups, which
was comparable to silymarin-treated animals.
Histopathological assessment of liver samples
Histopathological analysis revealed that the livers of con-
trol mice (Fig. 2a) and mice treated with MC alone
(Fig. 2b) had a normal histoarchitecture. CCl4 intoxica-
tion induced a severe centrilobular necrosis and loss of
hepatic tissue, with mild inflammatory cell infiltration
around the central vein region and sinusoidal spaces
(Fig. 2c). In the livers of CCl4-intoxicated mice treated
with MC at doses of 50 mg/kg (Fig. 2d), 200 mg/kg
(Fig. 2e) and 400 mg/kg (Fig. 2f ) an improvement in the
morphology and reduction in both the size of necrotic
areas and inflammatory infiltration was observed. The
extent of hepatoprotection afforded by the extracts in
the MC400 group against the CCl4-induced liver injury
was similar to the reference compound silymarin (Fig. 2g
and 2h).
Antioxidant activity of M. croatica
Administration of CCl4 caused a significant decrease in
Cu/Zn SOD activity (Table 1) and the increase in 4-
HNE formation (Fig. 3) when compared to control
group. Treatment with MC dose-dependently amelio-
rated changes in the hepatic Cu/Zn SOD activity and 4-
HNE formation. At the dose of 400 mg/kg MC caused a
similar increase in SOD activity and reduction of 4-HNE
production as in the reference group. Further analysis of
the antioxidant status in mice livers revealed low Nrf2
immunostaining in control mice (Fig. 4a). However, the
increase in Nrf2 immunopositivity in the cytoplasm and
the nuclei of hepatocytes and in Kupffer cells of mice
treated with MC alone (Fig. 4b) as well as in mice intoxi-
cated with CCl4 (Fig. 4c) was observed. Furthermore, a
dose-dependent manner increase in Nrf2 immunostain-
ing intensity was detected after administration of MC
(Fig. 4d, e and f). High expression of Nrf2 was also
found in the livers of silymarin-treated group (Fig. 4g),
which was comparable to MC400 (Fig. 4h). Western blot
analysis showed that HO-1 protein expression in the
liver of control mice was negligible (Fig. 7). The expres-
sion of HO-1 significantly increased in the livers of
CCl4-treated mice. Interestingly, administration of MC
resulted in a dose-dependent increase in hepatic HO-1
protein expression. No statistically significant difference
in HO-1 levels was observed between MC400 and sily-
marin groups.
Anti-inflammatory activity of M. croatica
Immunohistochemical analysis of the NF-κB expression
showed low expression of NF-κB p65 in the livers of
control mice (Fig. 5a) and mice treated with MC alone
(Fig. 5b), whereas strong NF-κB immunopositivity was
found in the livers of CCl4-treated animals (Fig. 5c).
Treatment with MC at 50, 200 or 400 mg/kg reduced
NF-κB p65 immunopositivity in a dose dependent man-
ner (Fig. 5d, e and f). Low expression of NF-κB was also
found in the livers of silymarin-treated group (Fig. 5g),
which was comparable to MC400 (Fig. 5h). Western blot
analysis revealed that TNF-α protein expression in the
livers of control and MC treated mice was negligible
(Fig. 7). CCl4-intoxication significantly increased TNF-α
expression, however, oral administration of MC resulted
in a dose-dependent decrease in TNF-α production in
mice livers. The hepatic expression of TNF-α in
silymarin-treated mice did not show a statistically sig-
nificant difference compared to MC400 group.
Fig. 3 Western blot analysis of hepatic 4-hydroxynonenal (4-HNE)
expression. Line 1: control mice, Line 2: mice receiving MC 400 mg/kg,
Line 3: CCl4-intoxicated mice, Lines 4, 5 and 6: mice secondary treated
by MC at doses of 50 mg/kg, 200 mg/kg and 400 mg/kg, respectively,
Line 7: mice treated by silymarin at dose of 400 mg/kg. Each value
represents the mean ± SD (n = 5). Means sharing the same letter are
not significantly different from each other (P < 0.05)
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Antifibrotic potential of M. croatica
In the livers of control mice and MC group α-SMA im-
munoreactivity was not detected, except sporadically in
the wall of blood vessels (Fig. 6a and b). In contrast, nu-
merous α-SMA-positive cells emerged in the livers of
CCl4-treated mice, indicating activation of hepatic stel-
late cells (HSC) (Fig. 6c). α-SMA immunopositivity was
substantially reduced by oral administration of MC in a
dose-dependent manner (Fig. 6d, e and f). The expres-
sion of α-SMA in the livers of MC400 group was similar
to silymarin-treated mice (Fig. 6g and h). Changes in
hepatic TGF-β1 expression coincided with changes in α-
SMA immunopositivity, showing an increase in CCl4-
intoxicated mice and a subsequent decrease by the MC
treatment (Fig. 7). TGF-β1 and α-SMA expressions in
the livers of MC400 group were comparable to mice re-
ceiving an equal dose of silymarin (Fig. 6h and 7).
Discussion
In this study, we demonstrated that ethanolic extract of
aerial parts of Micromeria croatica has preventive effect
on CCl4-induced hepatic injury and fibrosis. Carbon
tetrachloride (CCl4) is a potent hepatotoxin capable of
causing experimental hepatic damage through the cyto-
chrome P450-mediated activation to free radicals and re-
active species, which in turn induce hepatocyte necrosis,
inflammation and, subsequently, lead to liver fibrosis.
Highly reactive radicals generated from CCl4, as trichlor-
omethyl (·CCl3) and trichloromethyl peroxyl (
·OOCCl3),
affect the hepatocytes and cause structural and functional
Fig. 4 Hepatic NF-E2-related factor 2 (Nrf2) expression. Nrf2 immunostaining in control mice (a) and mice receiving MC 400 mg/kg (b). Nrf2
immunoreactivity in CCl4-intoxicated mice (c) and mice secondary treated by MC at doses of 50 mg/kg (d), 200 mg/kg (e) and 400 mg/kg (f) and
silymarin at dose of 400 mg/kg (g). Original magnification 400x. Representative results from 5 similarly treated mice. Each value represents the
mean ± SD (n = 5). Measurement of the Nrf2 immunostaining intensity (h). Means sharing the same letter are not significantly different from each
other (P < 0.05)
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changes of their cellular membranes [21]. Our experiment
showed that mice intoxicated with CCl4 developed a sig-
nificant liver necrosis and oxidative stress, evidenced by a
significant increase in the serum activity of ALT and im-
paired antioxidant status in the liver. The results of this
study showed that the antioxidant constituents of MC
acted against the damaging effects of free radicals pro-
duced by CCl4. The restoration towards normal level of
serum ALT, the most sensitive biochemical marker of hep-
atocyte injury, indicated that MC preserved the structural
integrity of hepatocellular membrane and protected the
liver from the harmful effects of this hepatotoxin, which
was additionally supported by the histological findings.
Moreover, hepatoprotective effect of MC was accompan-
ied by the amelioration of inflammation and an early onset
of fibrogenesis in injured livers.
A number of recent studies suggested that the antioxi-
dant activity against free radicals may be an important
mechanism of the hepatoprotection [4, 5, 18, 22]. MC
was found to possess significant in vitro antioxidant
property, being capable of directly quenching free radi-
cals resulting in the termination of the radical chain re-
action, act as reducing agent, and chelate transition
metals to suppress the initiation of radical formation [10].
Considerable antioxidant effects of MC, mainly attributed
to the high level of phenolic compounds, especially ros-
marinic acid, indicates that M. croatica could be useful in
the prevention or amelioration of oxidative damage. In ex-
perimental animals, CCl4-mediated oxidative stress is as-
sociated with a lower antioxidant capacity of hepatic cells,
characterized by a decreased functioning of the enzymatic
and non-enzymatic defence mechanisms [23].
Fig. 5 Nuclear factor-kappaB (NF-κB) p65 expression in the livers. NF-κB immunostaining in control mice (a) and mice receiving MC 400 mg/kg
(b). NF-κB immunoreactivity in CCl4-intoxicated mice (c) and mice secondary treated by MC at doses of 50 mg/kg (d), 200 mg/kg (e) and 400 mg/kg
(f) and silymarin at dose of 400 mg/kg (g). Original magnification 400x. Representative results from 5 similarly treated mice. Measurement of the NF-κB
immunostaining intensity (h). Means sharing the same letter are not significantly different from each other (P < 0.05)
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Acting as a first line of antioxidant defence, Cu/Zn
SOD is a key enzyme in the cellular defence against the
deleterious action of free radicals and other ROS, which
in turn readily inactivate it. Considering that membrane
lipids are the most susceptible to oxidative attack, the
lipid peroxidation is recognized to be one of the major
contributors to oxidative cell death and tissue injury.
Increased steady-state level of the 4-hydroxynonenal
(4-HNE), which is important end product of lipid per-
oxidation, is often taken as a specific marker of oxida-
tive stress [24]. In the current study, SOD activity was
brought to increase while 4-HNE decreased by the MC
treatment of CCl4-intoxicated mice, evidently demon-
strating its antioxidant effectiveness in vivo.
In order to clarify the mechanism of hepatoprotection,
the effect of MC on activation of the Nrf2/HO-1 path-
way was examined. Nrf2 is a key transcription factor
which plays a central role in cellular defence against oxi-
dative stress, inducing expression of a variety of cytopro-
tective and phase-2 detoxifying genes [25]. Heme
oxygenase-1 (HO-1), one of the most important cytopro-
tective enzymes, has been shown to have a putative role
in several different models of hepatic injury [26]. This
inducible enzyme catalyzes the rate-limiting step of free
heme degradation into free iron, carbon monoxide, and
biliverdin, the last of which is subsequently catabolised
into bilirubin, a potent endogenous antioxidant [27].
Furthermore, HO-1 functions as a suppressor of the
proinflammatory TNF-α/NF-κB signalling pathway by
diminishing intracellular ROS production [12]. There-
fore, HO-1 is recognized as an important therapeutic
target for pharmacological intervention of liver injury.
The present study revealed MC-induced increase in
Nrf2 and HO-1 expression in CCl4-intoxicated mice
Fig. 6 Hepatic alpha-smooth muscle actin (α-SMA) expression. α-SMA immunostaining in control mice (a) and mice receiving MC 400 mg/kg (b).
α-SMA immunoreactivity in CCl4-intoxicated mice (c) and mice secondary treated by MC at doses of 50 mg/kg (d), 200 mg/kg (e) and 400 mg/kg
(f) and silymarin at dose of 400 mg/kg (g). Original magnification 400x. Representative results from 5 similarly treated mice. Measurement of the
α-SMA immunostaining intensity (h). Means sharing the same letter are not significantly different from each other (P < 0.05)
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livers. High levels of these proteins were also determined
in the livers of intoxicated mice treated with silymarin.
These results are in agreement with other studies, which
indicated that natural phenolics exert hepatoprotective
effects via HO-1 induction [28, 29]. The induction of
HO-1 via Nrf2 signalling by MC may provide an effective
means for achieving cellular protection. Most recently,
Park et al. [30] demonstrated that the induction of HO-1
was critical for anti-inflammatory effect of Inula helen-
ium extract in LPS-activated RAW 264.7 macrophages.
The NF-κB pathway plays a central role in the inflam-
matory response. This pathway is activated upon appro-
priate cellular stimulation, most often by signals related
to pathogens or stress [31]. Regulation and control of
NF-κB activation can be a powerful therapeutic strategy
for reducing tissue damage or other complications as a
consequence of the release of inflammatory mediators.
Several naturally occurring inhibitors of NF-κB, including
caffeic acid, curcumin, resveratrol and silymarin, demon-
strated antinecrotic, anticholestatic, antifibrotic and antican-
cer effects in the liver of experimental animals [32]. NF-κB
activation, induced by oxidative stress, modulates hepatic
damage by triggering cytotoxic cytokine production [33].
TNF-α is a proinflammatory cytokine that is rapidly pro-
duced in response to tissue injury and identified to be a key
regulator of the inflammatory response. This pleiotropic
cytokine stimulates the release of other cytokines from mac-
rophages and induces the phagocyte oxidative metabolism
as well as production of nitric oxide that can aggravate oxi-
dative stress [34]. As we previously reported [18, 20, 35],
natural antioxidants can significantly ameliorate proinflam-
matory response. In the current study, treatment with MC
reduced NF-κB activation and TNF-α protein expression,
suggesting the anti-inflammatory activity of MC.
Oxidative stress-related molecules may stimulate cellu-
lar events required for the development of liver fibrosis
[36]. CCl4 is assumed to initiate free radical-mediated
lipid peroxidation, leading to the accumulation of lipid-
derived oxidation products that cause liver injury and
excess collagen deposition in the liver, resulting in liver
fibrosis [37]. Infiltration of inflammatory cells could con-
tribute to hepatic oxidative stress and fibrogenesis. Ali et
al. [38] showed that these cells, at least in part, belong to
CD68+ macrophages, which have been suggested as im-
portant activators of hepatic HSCs [39]. Transforming
growth factor-β1 (TGF-β1) is generally accepted as the
Fig. 7 Western blot of hepatic tumor necrosis factor-alpha (TNF-α), transforming growth factor-beta 1 (TGF-β1) and heme oxygenase-1 (HO-1)
expression. Line 1: control mice, Line 2: mice receiving MC 400 mg/kg, Line 3: CCl4-intoxicated mice, Lines 4, 5 and 6: mice secondary treated by
MC at doses of 50 mg/kg, 200 mg/kg and 400 mg/kg, respectively, Line 7: mice treated by silymarin at dose of 400 mg/kg. Each value represents
the mean ± SD (n = 5). Means sharing the same letter are not significantly different from each other (P < 0.05)
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main profibrotic factor. Our previous research pointed
out that antioxidants of plant origin, such as delphinidin
and oleuropein [20, 35] possess antifibrotic potential
through down-regulation of TGF-β1 expression. In the
present study, MC treatment markedly suppressed
TGF-β1 production, which coincided with decreased α-
SMA expression, an indicator of HSC inactivation, sug-
gesting a potential to prevent an early onset of hepatic
fibrogenesis. Rosmarinic acid, the most abundant poly-
phenolic constituent found in MC and a strong antifi-
brotic agent [18, 40], is very likely to contribute to the
observed effect.
Conclusions
The present study demonstrated for the first time the
therapeutic properties of MC against liver injury. In the
livers of chemically-intoxicated mice, the MC treatment
was found to ameliorate oxidative stress, inflammation
and fibrogenesis. Hepatoprotective and antifibrotic ef-
fects of MC were comparable to those of silymarin, a
well known standard hepatoprotectant. These findings
suggest that M. croatica could be useful in the treatment
of acute liver injury and encourage further research to
assess its value in modern phytotherapy.
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